Skip to main content
Clinical Trials/ISRCTN12449681
ISRCTN12449681
Active, not recruiting
未知

Psychoanalytic therapy (PT) and cognitive-behavioral therapy (CBT) in outpatients with anxiety (panic disorder/agoraphobia) and comorbid personality disorders: a multicenter prospective randomized superiority trial

German Society for Psychoanalysis, Psychotherapy, Psychosomatics and Depth Psychology (DGPT) (Germany)0 sites200 target enrollmentDecember 12, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
German Society for Psychoanalysis, Psychotherapy, Psychosomatics and Depth Psychology (DGPT) (Germany)
Enrollment
200
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

2016 protocol in https://pubmed.ncbi.nlm.nih.gov/27594602/ (added 15/02/2021)

Registry
who.int
Start Date
December 12, 2014
End Date
April 1, 2024
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
German Society for Psychoanalysis, Psychotherapy, Psychosomatics and Depth Psychology (DGPT) (Germany)

Eligibility Criteria

Inclusion Criteria

  • 1\. Panic disorder (including partial remission, i.e., maximally 2 months without significant symptoms) and/or agoraphobia plus:
  • 2\. At least one of the following PDs: avoidant PD, dependent PD, obsessive\-compulsive PD, depressive PD, negativistic PD, histrionic PD, borderline PD without acute suicidality, narcissistic PD, PD not otherwise specified (i.e., in at least two of the PD categories listed above only 1 criterion is missing to fulfill the diagnosis)
  • 3\. Age: at least 21 years

Exclusion Criteria

  • 1\. Bipolar affective disorder, psychotic disorder, acute eating disorder, substance\-related disorder (except caffeine and nicotine), Cluster\-A PDs, antisocial PD, borderline PD with acute suicidality
  • 2\. Neurological diseases (with psychologically significant consequences, e.g., epilepsy)
  • 3\. Insufficient knowledge of the German language
  • 4\. Strong preference for one of the two treatment conditions
  • 5\. Current medication with benzodiazepine

Outcomes

Primary Outcomes

Not specified

Similar Trials